Lenalidomide in Nonmetastatic Biochemically Relapsed Prostate Cancer: Results of a Phase I/II Double-Blinded, Randomized Study

PURPOSE: To evaluate the safety and activity of 6 months of treatment with lenalidomide at 5 or 25 mg/d in nonmetastatic biochemically relapsed prostate cancer. EXPERIMENTAL DESIGN: Sixty men with non-castrate, nonmetastatic, biochemically relapsed prostate cancer were stratified by prostate-specifi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Keizman, Daniel, Zahurak, Marianna, Sinibaldi, Victoria, Carducci, Michael, Denmeade, Samuel, Drake, Charles, Pili, Roberto, Antonarakis, Emmanuel S., Hudock, Susan, Eisenberger, Mario
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3444815/
https://ncbi.nlm.nih.gov/pubmed/20978144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-10-1928
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados